Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control

被引:80
作者
Gan, BY
Melkoumian, ZK
Wu, XY
Guan, KL
Guan, JL [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA
[2] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
关键词
D O I
10.1083/jcb.200411106
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FIP200 (focal adhesion kinase [FAK] family interacting protein of 200 kD) is a newly identified protein that binds to the kinase domain of FAK and inhibits its kinase activity and associated cellular functions. Here, we identify an interaction between FIP200 and the TSC1-TSC2 complex through FIP200 binding to TSC1. We found that association of FIP200 with the TSC1-TSC2 complex correlated with its ability to increase cell size and up-regulate S6 kinase phosphorylation but was not involved in the regulation of cell cycle progression. Conversely, knockdown of endogenous FIP200 by RNA interference reduced S6 kinase phosphorylation and cell size, which required TSC1 but was independent of FAK. Furthermore, overexpression of FIP200 reduced TSC1-TSC2 complex formation, although knockdown of endogenous FIP200 by RNA interference did not affect TSC1-TSC2 complex formation. Lastly, we showed that FIP200 is important in nutrient stimulation-induced, but not energy- or serum-induced, S6 kinase activation. Together, these results suggest a cellular function of FIP200 in the regulation of cell size by interaction with the TSC1-TSC2 complex.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 45 条
[1]   Regulation of focal adhesion kinase by a novel protein inhibitor FIP200 [J].
Abbi, S ;
Ueda, H ;
Zheng, CH ;
Cooper, LA ;
Zhao, JH ;
Christopher, R ;
Guan, JL .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (09) :3178-3191
[2]   Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [J].
Brugarolas, J ;
Lei, K ;
Hurley, RL ;
Manning, BD ;
Reiling, JH ;
Hafen, E ;
Witter, LA ;
Ellisen, LW ;
Kaelin, WG .
GENES & DEVELOPMENT, 2004, 18 (23) :2893-2904
[3]   Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B [J].
Catania, MG ;
Mischel, PS ;
Vinters, HV .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (07) :711-723
[4]   Isolation, characterization and mapping of the mouse and human RB1CC1 genes [J].
Chano, T ;
Ikegawa, S ;
Saito-Ohara, F ;
Inazawa, J ;
Mabuchi, A ;
Saeki, Y ;
Okabe, H .
GENE, 2002, 291 (1-2) :29-34
[5]   Truncating mutations of RB1CC1 in human breast cancer [J].
Chano, T ;
Kontani, K ;
Teramoto, K ;
Okabe, H ;
Ikegawa, S .
NATURE GENETICS, 2002, 31 (03) :285-288
[6]   Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells [J].
Chano, T ;
Ikegawa, S ;
Kontani, K ;
Okabe, H ;
Baldini, N ;
Saeki, Y .
ONCOGENE, 2002, 21 (08) :1295-1298
[7]   Preferential expression of RB1-inducible coiled-coil 1 in terminal differentiated musculoskeletal cells [J].
Chano, T ;
Saeki, Y ;
Serra, M ;
Matsumoto, K ;
Okabe, H .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) :359-364
[8]  
Dahiya R, 1998, INT J ONCOL, V12, P811
[9]   Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling [J].
Gao, XS ;
Zhang, Y ;
Arrazola, P ;
Hino, O ;
Kobayashi, T ;
Yeung, RS ;
Ru, BG ;
Pan, DJ .
NATURE CELL BIOLOGY, 2002, 4 (09) :699-704
[10]   Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 [J].
Garami, A ;
Zwartkruis, FJT ;
Nobukuni, T ;
Joaquin, M ;
Roccio, M ;
Stocker, H ;
Kozma, SC ;
Hafen, E ;
Bos, JL ;
Thomas, G .
MOLECULAR CELL, 2003, 11 (06) :1457-1466